Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings
Medtronic (NYSE:MDT) reported better-than-expected results and raised its FY27 EPS guidance. Analysts are bullish with raised price targets.
Medtronic did better than people thought it would, so experts who study the company think it will make more money in the future. When smart analysts feel more confident about a company's future, it can mean things are going well inside that business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.